DRUG FORMULATIONS FOR CANCER TREATMENT

Compounds and pharmaceutical formulations containing these compounds are described. Also described are methods of making and using the compounds. The compounds include nucleobases, nucleobase analogues, or combinations thereof. In one embodiment, a nucleobase analogue is combined with doxorubicin an...

Full description

Saved in:
Bibliographic Details
Main Authors BROTO, Marta, CAMACHO, Kathryn, M, MENEGATTI, Stefano, MITRAGOTRI, Samir
Format Patent
LanguageEnglish
French
German
Published 03.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds and pharmaceutical formulations containing these compounds are described. Also described are methods of making and using the compounds. The compounds include nucleobases, nucleobase analogues, or combinations thereof. In one embodiment, a nucleobase analogue is combined with doxorubicin and encapsulated within a liposome for use in inhibiting or preventing the growth of cancer cells. Further described are pharmaceutical compositions containing two or more therapeutically active agents encapsulated within a vesicle, such as a liposome, wherein the molar ratio of the agents provides a synergistic therapeutic effect.
Bibliography:Application Number: EP20160816494